ABSTRACT -Friedreich ataxia (FRDA), the most common autosomal recessive ataxia, is caused in 94% of cases by homozygous expansions of an unstable GAA repeat localised in intron 1 of the X25 gene. We have investigated this mutation in five Brazilian patients: four with typical FRDA findings and one patient with atypical manifestations, who was considered to have some other form of cerebellar ataxia with retained reflexes. The GAA expansion was detected in all these patients. The confirmation of FRDA diagnosis in the atypical case may be pointing out, as in other reports, that clinical spectrum of Friedreich's ataxia is broader than previously recognised and includes cases with intact tendon reflexes.
Friedreich ataxia (FRDA) (OMIM 229300) 1 is the most common autosomal recessive ataxia, with an estimate frequency of 1/50 000-2/50 000 2 . Until recently, the usual criteria for its clinical diagnosis included: onset of cerebellar ataxia at <20 years old, absence of lower-limb deep-tendon reflexes, extensor plantar responses, reduction of vibratory sense, cardiomyopathy and a predisposition to diabetes mellitus. These criteria excluded patients with late-onset disease, as well as those with retained reflexes. The latter ones were considered to have distinct diseases, such as "early onset cerebellar ataxia with retained reflexes" (EOCA) (OMIM 212895) 1, 3 .
In 1996, the FRDA gene was cloned 4 present in the first intron of this gene. The GAA motif is present from 7 to 22 times in the normal population. In FRDA population, however, it is amplified 200-900 times. This expansion results in a decreased expression of the target frataxin gene, and it is meiotically and mitotically unstable. Further analysis revealed that frataxin is encoded as part of the STM7 gene 5 , and that the repetitive motif is localised in the intron 18 of the STM7 gene, which encodes a catalytic domain of a phosphatidylinositol-4-phosphate-5-kinase. This enzyme has been proposed to be essential for vesicular trafficking or synaptic transmission, but its role on FRDA is still controversial 5 .
Yeasts deficient in frataxin homologue (YFH1) have respiratory incompetence and accumulate iron in mitochondria. On the other hand, iron deposits have been demonstrated in the heart of FRDA patients. Although the actual function of frataxin is not yet clear, these findings suggest that FRDA patients suffer from free radical toxicity causing mitochondrial dysfunction 6 .
The X25 gene cloning brought more strict diagnostic criteria for patients with classical or atypical FRDA manifestations. The purposes of this report are: (1) to present our first patients with molecular diagnosis of FRDA, and (2) to stress the necessary inclusion of atypical clinical pictures under this diagnosis.
METHODS
We have included five Brazilian patients in this study, four with clinical diagnosis of FRDA and one atypical patient. They all agreed on having the DNA analysis for the X25 gene performed.
Molecular analysis of four patients (Cases 1, 2, 3 and 5) included in this study were performed in Naples, Italy. The analysis in one of the patients (Case 4) was performed in our laboratory in Brazil. The DNA was extracted from peripheral blood leukocytes using the "salting out" precipitation method by Miller et al. 7 and amplified by PCR using the ELONGASE TM Enzyme Mix (GIBCO BRL) according to the manufacturers instructions. The primers and PCR conditions used for the analysis of the GAA repeats in the first intron of the X25 gene were described by Filla et al. 8 , which generated PCR products of 500+3n base pairs (n: number of GAA triplets). These fragments were then submitted to electrophoresis in a 1% agarose gel and were separated by size. The expansions size analysis was estimated by comparison of the amplified fragment with a 1kb ladder (GIBCO BRL) using the calculations described by Southern 9 .
CASE REPORTS AND RESULTS

Typical cases
Case 1 was a 21 year-old man, the first son of healthy ,non-consanguineous parents of German ancestry. Since his first decade of life, he showed a progressive unstable gait. On physical examination, he had limb and ocular ataxia, absence of myotatic reflexes and extensor plantar responses. Sensory and motor conduction velocities were very reduced. Brain magnetic resonance images (MRI) were normal. On electrocardiogram (EKG), there were signs of overload and left ventricular hypertrophy.
His 9 and 15 year-old sisters were asymptomatic, and DNA study was not performed.
X25 gene analysis showed 641 GAA repeats in both chromosomes.
Case 2 was a 44 year-old woman, with healthy and consanguineous (first cousins) parents. Among her 9 siblings, 3 were also affected. Unfortunately, none of the siblings could be examined. She showed gait ataxia since 18 years old, being, at the time of examination, dependent of wheelchair. On physical examination, ataxia kept her from walking or standing up; there were also limb incoordenation, absence of tendon reflexes, extensor plantar responses and loss of vibratory sense on the legs. Neurophysiological studies revealed a mixed, mainly sensitive neuropathy.She presented tricuspid insufficiency on echocardiogram, and T wave abnormalities on EKG.
She had 442 and 553 GAA repeats respectively in each allele of the X25 gene.
Case 3 was a 12 year-old girl, daughter of consanguineous (first cousins) parents. Aside from ataxia, she also showed a familial brachydactyly, inherited from her father as an autosomal dominant trait. She started with frequent falls and a progressive scoliosis from the age of 4, showing, in the following years, dysarthria and ataxic gait. On physical examination, she showed dysmetria, absence of myotatic reflexes, flexor plantar responses and vibration and position sense loss. On conduction nerve studies, there were reduction of motor and sensory velocities, and on echocardiogram there was a left ventricular hypertrophy.
Her 10 year-old sister did not have FRDA symptoms. Her DNA analysis was not performed.
The analysis of the X25 gene in this patient showed homozygosity for 955 GAA repeats.
Case 4 was a 27 year-old woman, the first daughter of healthy, non-consanguineous parents. After her birth, it was noticed that she had unilateral cleft lip. There was familial history of this anomaly: one maternal uncle and one paternal uncle also have cleft lip. She has showed progressive gait ataxia since 12 years old. In the following years, she began with dysarthria and frequent falls. On physical examination, she displayed dysarthria, appendicular ataxia, absence of myotatic reflexes, extensor plantar responses and position sense loss; ataxia kept her from walking alone. She presented mild tricuspid and mitral insufficiency on echocardiogram. Her CT scan was normal.
Her sister was 23 year-old, and did not have FRDA symptoms. Her DNA analysis was not performed.
X25 gene analysis showed heterozygosity for 759 and 875 GAA repeats (Fig 1) . 
Atypical case
Case 5 was a 30 year-old man, the fifth son of healthy, non-consaguineous parents of Italian ancestry. He had two sibs also affected. His ataxia began at 25 years old. On physical examination he displayed dysarthria, truncal and apendicular ataxia, nystagmus and loss of vibratory sense on both legs. Deep-tendon reflexes were, however, preserved, and the plantar responses were flexor. There was mild cerebellar atrophy on CT scan. Cardiological evaluation was normal. The normal reflexes (including the plantar responses), the late onset of the disease and the absence of cardiac involvement were all atypical findings.
The X25 gene analysis in this patient showed 224 and 955 GAA repeats respectively for each allele.
DISCUSSION
The trinucleotide repeat expansions are now a well known mutagenic mechanism in human genetics. Friedreich ataxia, FRDA, is the first autosomal recessive disease associated to this mechanism: GAA expansion is detected in all patients, most (94%) of them being homozygous for the mutation 10 . Compound heterozygotes carrying a trinucleotide expansion on one parental allele and a point mutation on the other may account for the 5-6% of patients with FRDA 11 .
Besides confirming the clinical diagnosis of FRDA in four patients with typical manifestations, the molecular investigations determined the same diagnosis in an atypical patient (Case 5). This patient had a late-onset of symptoms (25 years of age), preserved reflexes, flexor plantar responses and normal cardiological evaluation.
As many other cases with retained reflexes and/or with late-onset were diagnosed by molecular analysis as FRDA 10, 12 , the existence of other forms of autosomal recessive cerebellar ataxia without biological markers, such as EOCA, is doubtful. They probably represent FRDA variants with lateonset (LOFA) or with retained reflexes (FARR).
The size of GAA expansions, in our cases, were smaller than those found by Filla et al. in 67 European patients 13 . These authors found expanded alleles with 201-1186 GAA repeats. The mean, in that study, was of 816 repeats, with a SD of 188: our mean is 700. This probably happened because of the small size of our sample.
It is known that there is an inverse correlation between the size of the smaller expanded allele and the age of onset and severity of FRDA 14 . One of our five patients showed LOFA (Case 5, also being described as atypical, or as a case of FARR). This patient has the smallest expanded alelle of our sample (224 GAA repeats), which could explain the milder form of his disease.
In Cases 2 and 3, the two expanded alleles have the same origin. The parents are consanguineous (first cousins in both cases). While in Case 3 the expansion seemed to be stable (as only one PCR amplification product of GAA repeats was seen on the lane, corresponding to 955 repeats), in Case 2 the mutation proved to be unstable (442/553 repeats). Monrós et al. also observed allelic size variation in some FRDA patients expected to be homozygous by descent 10 . This phenomenon can be explained by meiotic instability of the GAA-trinucleotide repeat.
In Case 1, on the other hand, the two expanded alleles have not the same origin. However, we have observed only one PCR amplification product of GAA repeats on the lane, corresponding to 641 repeats. As point mutations in the gene X25 have low frequency 13 and this patient has typical findings of FRDA, we believe that he has two expanded repeats of the same size (641/641).
In conclusion, we stress the significance of FRDA direct molecular diagnosis as an essential tool in clinical practice, mainly for confirming the diagnosis of atypical cases.
